Loading...
Keywords
Last Name
Institution

Ryan Fischer

Concepts (289)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
15
2023
39
5.240
Why?
Liver Diseases
6
2023
17
2.230
Why?
Muscular Dystrophy, Duchenne
9
2024
16
1.320
Why?
Humans
52
2026
8529
1.310
Why?
Alagille Syndrome
5
2025
5
1.110
Why?
Male
32
2025
4255
1.020
Why?
Immunosuppressive Agents
6
2019
38
1.020
Why?
Sirolimus
6
2019
9
0.970
Why?
Child
29
2025
4199
0.960
Why?
Postoperative Complications
4
2020
194
0.900
Why?
Female
27
2025
4443
0.850
Why?
Fontan Procedure
2
2021
26
0.820
Why?
Thrombosis
1
2023
20
0.800
Why?
Dendritic Cells
4
2011
8
0.800
Why?
Child, Preschool
18
2025
2010
0.720
Why?
Patient Compliance
2
2020
64
0.680
Why?
Clinical Laboratory Techniques
1
2020
11
0.670
Why?
Cryptosporidiosis
1
2020
2
0.670
Why?
Immunocompromised Host
1
2020
13
0.660
Why?
Infant
17
2025
1841
0.650
Why?
Retrospective Studies
15
2023
1603
0.640
Why?
Adolescent
19
2025
2766
0.630
Why?
Cholangitis, Sclerosing
3
2026
3
0.620
Why?
Anemia, Hemolytic, Congenital
1
2019
3
0.610
Why?
Neoplasms
1
2021
151
0.610
Why?
Hydrops Fetalis
1
2019
6
0.600
Why?
Electronic Health Records
1
2019
85
0.590
Why?
Graft Rejection
3
2020
34
0.550
Why?
Foot Dermatoses
1
2017
1
0.540
Why?
Pagetoid Reticulosis
1
2017
1
0.540
Why?
Skin Neoplasms
1
2017
10
0.530
Why?
Immune Tolerance
3
2021
11
0.520
Why?
Intestines
2
2013
37
0.510
Why?
Adult
12
2025
1446
0.500
Why?
Treatment Outcome
12
2026
717
0.490
Why?
Bile Acids and Salts
3
2025
3
0.480
Why?
Vancomycin
3
2026
19
0.470
Why?
Animals
6
2021
817
0.460
Why?
Intestinal Atresia
1
2013
9
0.420
Why?
Caregivers
4
2025
58
0.420
Why?
Immunologic Deficiency Syndromes
1
2013
18
0.420
Why?
CD8-Positive T-Lymphocytes
2
2022
17
0.400
Why?
Hypertension, Portal
2
2022
5
0.380
Why?
Isoantigens
2
2011
2
0.370
Why?
Myeloid Cells
1
2011
3
0.350
Why?
Non-alcoholic Fatty Liver Disease
2
2022
22
0.350
Why?
Histocompatibility Antigens Class I
1
2011
12
0.350
Why?
Bone Marrow Transplantation
1
2011
18
0.350
Why?
Hepatolenticular Degeneration
1
2011
1
0.350
Why?
Anti-Bacterial Agents
3
2026
313
0.350
Why?
Cholestasis, Intrahepatic
2
2021
3
0.330
Why?
Genetic Therapy
2
2021
9
0.330
Why?
Heart Defects, Congenital
2
2023
120
0.330
Why?
Fatty Liver
2
2013
6
0.330
Why?
Short Bowel Syndrome
3
2015
6
0.320
Why?
Young Adult
9
2025
838
0.320
Why?
Patient Participation
2
2020
20
0.310
Why?
Patient Preference
3
2019
7
0.300
Why?
Prospective Studies
4
2023
595
0.290
Why?
Cholestasis
2
2025
5
0.260
Why?
Liver Failure
2
2019
2
0.240
Why?
United States
5
2025
829
0.240
Why?
Growth Charts
1
2025
6
0.240
Why?
Liver Cirrhosis
3
2023
7
0.240
Why?
Inflammatory Bowel Diseases
1
2026
40
0.240
Why?
T-Lymphocytes, Regulatory
2
2020
8
0.230
Why?
Angelman Syndrome
1
2025
2
0.230
Why?
Forkhead Transcription Factors
2
2020
11
0.230
Why?
Transition to Adult Care
2
2022
22
0.220
Why?
Pruritus
1
2024
5
0.220
Why?
Quality of Life
3
2025
191
0.210
Why?
Comprehension
1
2023
6
0.210
Why?
Cardiomyopathies
1
2024
12
0.210
Why?
Platelet Aggregation Inhibitors
1
2023
3
0.210
Why?
Aspirin
1
2023
7
0.210
Why?
Hepatic Artery
1
2023
3
0.210
Why?
Vascular Diseases
1
2023
5
0.200
Why?
Anticoagulants
1
2023
22
0.200
Why?
Insurance
1
2023
4
0.200
Why?
Intestine, Small
2
2013
18
0.200
Why?
Digestive System Diseases
1
2022
1
0.190
Why?
Gastroenterology
1
2022
8
0.190
Why?
Bilirubin
4
2025
26
0.180
Why?
Tumor Microenvironment
1
2021
17
0.180
Why?
Patient Advocacy
3
2019
10
0.180
Why?
Killer Cells, Natural
1
2021
14
0.180
Why?
Heart Transplantation
2
2020
20
0.180
Why?
Endoscopy, Gastrointestinal
1
2022
18
0.180
Why?
Prognosis
3
2025
250
0.180
Why?
Risk Assessment
5
2021
177
0.180
Why?
Adenosine Triphosphatases
1
2021
3
0.180
Why?
T-Lymphocytes
2
2013
35
0.180
Why?
Cohort Studies
2
2020
341
0.180
Why?
Tacrolimus
2
2019
11
0.170
Why?
Attitude
1
2021
15
0.170
Why?
Aged, 80 and over
2
2021
170
0.170
Why?
Biliary Tract Diseases
1
2020
4
0.170
Why?
Diarrhea
1
2020
23
0.170
Why?
Weight Reduction Programs
1
2020
27
0.170
Why?
Diagnosis, Differential
2
2018
95
0.160
Why?
Pneumatosis Cystoides Intestinalis
1
2020
2
0.160
Why?
Liver Function Tests
1
2019
4
0.160
Why?
Anti-Inflammatory Agents
1
2019
14
0.160
Why?
Antipsychotic Agents
1
2019
14
0.160
Why?
Anticonvulsants
1
2019
35
0.160
Why?
CD4-Positive T-Lymphocytes
2
2011
16
0.150
Why?
Graft Survival
1
2019
34
0.150
Why?
Incidence
1
2019
139
0.150
Why?
Technology Assessment, Biomedical
1
2019
2
0.150
Why?
Ion Channels
1
2019
3
0.150
Why?
Uncertainty
1
2019
12
0.150
Why?
Ascites
1
2019
4
0.150
Why?
Research
1
2019
17
0.150
Why?
Hepatoblastoma
1
2019
6
0.150
Why?
Choice Behavior
1
2019
15
0.150
Why?
Liver Neoplasms
1
2019
14
0.150
Why?
Decision Making
1
2019
38
0.150
Why?
Drainage
1
2019
38
0.150
Why?
Transplantation Tolerance
2
2010
2
0.150
Why?
Middle Aged
4
2025
738
0.150
Why?
Thrombelastography
1
2018
1
0.140
Why?
Tomography, X-Ray Computed
1
2019
133
0.140
Why?
Blood Transfusion
1
2018
11
0.140
Why?
Necrobiotic Xanthogranuloma
1
2018
1
0.140
Why?
Dissection
1
2018
4
0.140
Why?
Resuscitation
1
2018
12
0.140
Why?
Cicatrix
1
2018
6
0.140
Why?
Infant, Premature
1
2019
123
0.140
Why?
Skin
1
2018
21
0.140
Why?
Liver
2
2022
126
0.140
Why?
Pregnancy
1
2019
257
0.140
Why?
Glucocorticoids
1
2018
43
0.140
Why?
Infant, Newborn
4
2025
1078
0.140
Why?
Pediatric Obesity
1
2020
179
0.130
Why?
Melanoma
1
2017
7
0.130
Why?
Carcinoma, Squamous Cell
1
2017
7
0.130
Why?
Intestinal Diseases
2
2013
4
0.130
Why?
Patient-Centered Care
3
2021
22
0.130
Why?
Health Resources
1
2015
24
0.120
Why?
Pneumonia, Aspiration
1
2015
9
0.120
Why?
Mice
3
2011
427
0.110
Why?
Genome-Wide Association Study
1
2015
198
0.110
Why?
Membrane Glycoproteins
2
2024
13
0.110
Why?
Kaplan-Meier Estimate
1
2013
31
0.110
Why?
Stem Cell Transplantation
1
2013
16
0.110
Why?
Mice, Inbred BALB C
2
2011
27
0.110
Why?
Carrier Proteins
2
2024
42
0.100
Why?
Graft vs Host Disease
1
2013
16
0.100
Why?
Severity of Illness Index
2
2013
204
0.100
Why?
Parenteral Nutrition, Total
1
2013
5
0.100
Why?
Anemia, Hemolytic, Autoimmune
1
2013
1
0.100
Why?
Calcineurin
1
2013
1
0.100
Why?
Pancreas Transplantation
1
2013
2
0.100
Why?
TOR Serine-Threonine Kinases
1
2013
4
0.100
Why?
Fish Oils
1
2013
2
0.100
Why?
Fat Emulsions, Intravenous
1
2013
2
0.100
Why?
Apoptosis
1
2012
57
0.090
Why?
Portal Vein
2
2023
6
0.090
Why?
Lymphocyte Activation
2
2009
9
0.090
Why?
Aged
2
2025
440
0.090
Why?
Transplantation, Isogeneic
1
2011
1
0.090
Why?
Cell Survival
1
2011
21
0.090
Why?
Mice, Knockout
1
2011
72
0.090
Why?
Surveys and Questionnaires
2
2025
370
0.090
Why?
Body Height
2
2025
50
0.080
Why?
Body Mass Index
2
2022
195
0.080
Why?
Biopsy
3
2018
63
0.080
Why?
Follow-Up Studies
2
2021
310
0.080
Why?
Chemotaxis
1
2009
2
0.080
Why?
Antigen Presentation
1
2009
3
0.080
Why?
Immunotherapy, Adoptive
1
2009
7
0.080
Why?
Metformin
1
2009
10
0.070
Why?
B-Lymphocytes
1
2009
27
0.070
Why?
Cytokines
1
2009
58
0.070
Why?
Randomized Controlled Trials as Topic
1
2009
71
0.070
Why?
Patient Education as Topic
1
2009
55
0.070
Why?
Recurrence
2
2019
112
0.070
Why?
Signal Transduction
1
2009
136
0.070
Why?
Data Collection
2
2021
29
0.070
Why?
Obesity
1
2009
154
0.070
Why?
Epitopes, T-Lymphocyte
1
2007
1
0.070
Why?
Allografts
2
2019
7
0.060
Why?
Steroids
2
2019
21
0.060
Why?
Pediatrics
2
2019
227
0.060
Why?
Disease Progression
2
2019
130
0.060
Why?
Administration, Oral
1
2026
71
0.060
Why?
Proportional Hazards Models
1
2025
39
0.060
Why?
Body Weight
1
2025
77
0.060
Why?
Cost of Illness
1
2025
24
0.060
Why?
United States Food and Drug Administration
2
2015
7
0.060
Why?
Health Care Costs
1
2025
33
0.060
Why?
Thiazepines
1
2024
1
0.050
Why?
Methylamines
1
2024
4
0.050
Why?
Double-Blind Method
1
2024
57
0.050
Why?
Exons
1
2024
51
0.050
Why?
Observational Studies as Topic
1
2023
3
0.050
Why?
Multicenter Studies as Topic
1
2023
22
0.050
Why?
Registries
1
2023
91
0.050
Why?
Parenteral Nutrition
1
2023
9
0.050
Why?
Biomarkers
1
2024
180
0.050
Why?
Immunity, Cellular
1
2022
17
0.050
Why?
Immunity, Humoral
1
2022
16
0.050
Why?
Prevalence
1
2023
193
0.050
Why?
Aspartate Aminotransferases
1
2022
5
0.050
Why?
Alanine Transaminase
1
2022
12
0.050
Why?
Patient Transfer
1
2022
10
0.050
Why?
Antibodies, Viral
1
2022
51
0.050
Why?
Societies, Medical
1
2022
66
0.050
Why?
Secondary Prevention
1
2022
9
0.050
Why?
Vaccination
1
2022
89
0.050
Why?
Gastrointestinal Hemorrhage
1
2022
13
0.050
Why?
Urban Population
1
2022
36
0.050
Why?
Bile Ducts, Intrahepatic
1
2021
1
0.040
Why?
Codon, Nonsense
1
2021
8
0.040
Why?
Survival Analysis
1
2021
45
0.040
Why?
Patients
1
2021
5
0.040
Why?
Risk-Taking
1
2021
11
0.040
Why?
Data Mining
1
2021
5
0.040
Why?
Rural Population
1
2022
62
0.040
Why?
Health Status
1
2021
31
0.040
Why?
Psychometrics
1
2021
39
0.040
Why?
Databases, Factual
1
2021
109
0.040
Why?
Ikaros Transcription Factor
1
2020
3
0.040
Why?
Protein Isoforms
1
2020
17
0.040
Why?
Age Factors
1
2021
250
0.040
Why?
Tissue and Organ Procurement
1
2019
14
0.040
Why?
Waiting Lists
1
2019
12
0.040
Why?
Risk
1
2019
42
0.040
Why?
Evidence-Based Practice
1
2019
19
0.040
Why?
Policy
1
2019
4
0.040
Why?
Algorithms
1
2020
120
0.040
Why?
Perception
1
2019
16
0.040
Why?
Clinical Decision-Making
1
2019
27
0.040
Why?
Cisplatin
1
2019
10
0.040
Why?
Cross-Sectional Studies
1
2021
419
0.040
Why?
Risk Factors
1
2021
545
0.040
Why?
Patient Safety
1
2019
25
0.040
Why?
Health Services Accessibility
1
2019
63
0.040
Why?
Antineoplastic Agents
1
2019
61
0.040
Why?
Kidney Diseases
1
2019
74
0.040
Why?
Quality Improvement
1
2019
95
0.040
Why?
Glomerular Filtration Rate
1
2019
117
0.040
Why?
Plasma
1
2018
6
0.040
Why?
Kidney
1
2019
107
0.040
Why?
Back
1
2018
1
0.040
Why?
Abdomen
1
2018
9
0.040
Why?
Thigh
1
2018
6
0.030
Why?
Parents
1
2019
218
0.030
Why?
Hospital Mortality
1
2015
31
0.030
Why?
Hospital Costs
1
2015
34
0.030
Why?
Socioeconomic Factors
1
2015
67
0.030
Why?
Inpatients
1
2015
44
0.030
Why?
Critical Illness
1
2015
30
0.030
Why?
Case-Control Studies
1
2015
255
0.030
Why?
Intensive Care Units, Neonatal
1
2015
61
0.030
Why?
Length of Stay
1
2015
260
0.030
Why?
Models, Statistical
1
2014
35
0.030
Why?
Transaminases
1
2013
2
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2013
1
0.030
Why?
Plasmapheresis
1
2013
3
0.030
Why?
Transplantation
1
2013
2
0.030
Why?
Hemolysis
1
2013
4
0.030
Why?
Everolimus
1
2013
2
0.030
Why?
Rituximab
1
2013
4
0.030
Why?
Cyclosporine
1
2013
7
0.030
Why?
Cyclophosphamide
1
2013
11
0.030
Why?
Medical Records
1
2013
16
0.030
Why?
Penicillins
1
2013
8
0.030
Why?
Immunoglobulins, Intravenous
1
2013
13
0.030
Why?
Nebraska
1
2013
2
0.030
Why?
Intestinal Volvulus
1
2013
9
0.030
Why?
Academic Medical Centers
1
2013
13
0.030
Why?
Hyperbilirubinemia
1
2013
9
0.030
Why?
Triglycerides
1
2013
27
0.020
Why?
Nephrotic Syndrome
1
2013
28
0.020
Why?
Hospitalization
1
2015
286
0.020
Why?
Gastroschisis
1
2013
18
0.020
Why?
Epithelium
1
2012
4
0.020
Why?
Observer Variation
1
2012
15
0.020
Why?
Time Factors
1
2013
280
0.020
Why?
Reproducibility of Results
1
2012
246
0.020
Why?
Flow Cytometry
1
2010
30
0.020
Why?
Cells, Cultured
1
2010
86
0.020
Why?
Bone Marrow Cells
1
2007
5
0.020
Why?
Mice, Inbred C3H
1
2007
5
0.020
Why?
Histocompatibility Antigens Class II
1
2007
6
0.020
Why?
Down-Regulation
1
2007
17
0.020
Why?
Up-Regulation
1
2007
27
0.020
Why?
Mice, Inbred C57BL
1
2007
126
0.020
Why?
Fischer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_